Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that was approved in 2017 as a treatment method for
improving glycemic control in patients with Type 2 diabetes. More recently Semaglutide was approved by the
FDA for non-diabetic weight loss.
Studies have demonstrated that Semaglutide reduced appetite, improved control of eating, and reduced
food cravings in addition to improved glycemic control.
The greatest weight loss benefits were observed
when Semaglutide is used in combination with lifestyle changes, such as improved diet and consistent
FREQUENTLY ASKED QUESTIONS
how does semaglutide + b12 work?
GLP-1 is a hormone produced in the small intestine that stimulates insulin secretion and inhibits glucagon
secretion, thereby lowering blood sugar.
Semaglutide + B12 has demonstrated beneficial effects on glycemia, in addition to a host of other benefits.
how much semaglutide + b12 do i inject?
Start with 0.25mL once weekly, increase to 0.5mL if needed/tolerated.
how should semaglutide + b12 be used?
Semaglutide + B12 is a subcutaneous injection which is most commonly dosed at 0.25mL(0.5mg) to
0.5mL(1mg) once weekly. This dosing may be increased to 1mL(2mg) once weekly after one month of
treatment if needed.
This medication is generally well-tolerated and can be dosed continuously without breaking treatment with
no diminishing effects.
The most commonly reported side effects include nausea, vomiting, diarrhea, stomach pain, and
constipation. The risk of serious side effects increases in patients with hypoglycemia, kidney problems, and
risk of allergic reactions.